EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 10.48 Delayed Data As of May 17 |  +0.28 / +2.75%Today’s Change | 7.30 Today|||52-Week Range 21.50 | -14.38% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 19.1M | 15.3M | 16.9M | 38.8M | |
| Short Term Investment Cash | 3.8M | -3.8M | 1.6M | 21.9M | ||
| Cash & Short Term Investments | 28.5M | 29.0M | 16.9M | 38.8M | ||
| Receivables | Receivables | 622.0K | 488.0K | 251.0K | 353.0K | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | -- | -- |
| Current Assets | Other Current Assets | 681.0K | 483.0K | 591.0K | 780.0K | |
| Current Assets | 29.8M | 30.0M | 17.7M | 39.9M | ||
| Total Assets | Property, Plant and Equipment - Gross | 2.1M | 2.0M | 799.0K | 906.0K | |
| Depreciation | -1.8M | -1.7M | -486.0K | -653.0K | ||
| Intangible Assets | 1.9M | 1.1M | 364.0K | 31.4M | ||
| Other Assets | 2.0M | 1.2M | 474.0K | 31.4M | ||
| Total Assets | 32.4M | 31.6M | 18.7M | 71.7M | ||
| Liabilities | Accounts Payable | 744.0K | 1.4M | 1.0M | 2.9M | |
| Accrued Expenses | 1.8M | 2.3M | 2.6M | 16.7M | ||
| Other Current Liabilities | 1.9M | 2.4M | 2.6M | 17.0M | ||
| Other Liabilities | 3.3M | 5.1M | 5.3M | 21.7M | ||
| Total Liabilities | Long Term Debt | 0.00 | 0.00 | 0.00 | 17.3M | |
| Other Liabilities | 55.0K | 60.0K | 51.0K | 21.0M | ||
| Total Liabilities | 9.0M | 10.7M | 5.3M | 60.0M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 23.4M | 20.9M | 13.3M | 11.7M | ||
| Total Shareholder Equity | 23.4M | 20.9M | 13.3M | 11.7M | ||
| Share Information | Common Shares Outstanding | 29.4M | 34.2M | 39.4M | 74.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
